Trairatvorakul, who gave a keynote speech on Thai businesses on the path to sustainable growth. From the Tom Yam Kung crisis 20 years ago, Thai businesses have made great improvements in strategic risk

leads to product development and finally expanding company business, increasing sales growth and profit return in the future Please be informed accordingly. Yours Sincerely, (Mr. Suchat Mongkhonaripong

result of favorable sales growth in Vietnam and Myanmar markets. Profit for the period L&E’s consolidated profit for the period of Q1/2018 was posted at Baht 19.9 million, up 485 % or Baht 16.5 million

from July 2020 with a promising growth. 2 Profit/(Loss) After Taxation (“PAT”)/(“LAT”) 2.1 PAT/(LAT) for the 3-months ended 31 July 2020 INGRS registered loss after taxation of Baht 107.53 million for

%, compared with the same period of the last year. As a result of operating profit that significant growth and finance costs are very low level because of the stable financial position. DOD BIOTECH PUBLIC

revenues growth at 36.5% and net profit growth at 28.9 which is in line with the Company’s target Q3/2019 Q3/2018 Change 9M/2019 9M/2018 Change MB MB % MB MB % Services income from debts collection and

associated company can decrease the cost from this investment. From this joint investment, Thippayabadin Company Limited can growth in revenue and profit. So, Ramkhamhaeng will receive benefit come back in

101.48 million or 65.46%, which was in line with the sharp rising in revenues from sales in this period. Gross profit margin in year 2018 was 61.51%, going up by 59.98% year-on-year. The growth in year

in revenues from sales in this period. Gross profit margin in Q3/2018 was 63.46%, going up by 59.09% year-on-year. The growth in Q3/2018 gross profit margin was mainly driven by the adoption of

Company’s net profit attributable to equity holders of the parent was THB 16.62 million which was equal to the net profit margin of 7.41 percent. A growth in net profit for 3-month period ended March 31, 2019